Similarly germline loss of inhibitory TIM3 can result in a severe systemic inflammatory condition called haemophagocytic lymphohistiocytosis (HLH) that can complicate rheumatic diseases such as adult onset Still's disease, but this has not been reported with anti‐TIM3 therapy to date. The gene discussed is HAVCR2; the disease is rheumatic disorder.